Senti Biosciences Inc (SNTI)

Senti Biosciences Inc. has seen no insider trading activity within the last 90 days. The most recent transactions occurred in February 2025, involving sales by the CEO and the President & Chief Medical & Development Officer. Prior to that, a proposed sale was recorded in December 2024 by a former affiliate.
Ticker: SNTI Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 6 Feb 2025
Value US$2,866,541.41 | Price 498.60 | Shares 92,141 (-31.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-06 2025-02-06 S Sale

CEO

Executive Director
92,141 -31.0%
498.60
US$2,866,541
92,141 -31.0% 498.60 US$2,866,541
2025-02-06 2025-02-06 S Sale

Pres. & Chief Med. & Dev. Off.

Officer
47,610 -24.1%
19.04
US$4,141,175
47,610 -24.1% 19.04 US$4,141,175
2025-02-06 2025-02-04 S Sale

CEO

Executive Director
96,176 -4.7%
431.29
US$623,735
96,176 -4.7% 431.29 US$623,735
2025-02-06 2025-02-04 S Sale

Pres. & Chief Med. & Dev. Off.

Officer
1,297 -12.8%
4.07
US$5,279
1,297 -12.8% 4.07 US$5,279
2024-12-02 2024-12-02 PrS Proposed sale

Former Affiliate

83,277
2.16
US$179,878
83,277 2.16 US$179,878